Related Experiment Video
Updated: Jun 17, 2026

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System
Published on: December 21, 2019
DOCK11 promotes HBV cccDNA formation through a PARP1-dependent mechanism.
Hideo Takayama1, Kouki Nio1, Kazuyuki Kuroki1
1Department of Gastroenterology, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.
Dedicator of cytokinesis 11 (DOCK11) promotes Hepatitis B virus (HBV) persistence by aiding the formation of viral cccDNA. Targeting DOCK11 may offer new therapies to reduce cccDNA and cure chronic HBV infection.
Area of Science:
- Hepatology and Virology
- Molecular Biology and Biochemistry
Background:
- Hepatitis B virus (HBV) infection persists due to stable cccDNA in hepatocytes, driving chronic liver disease and cancer.
- Current antiviral therapies are ineffective against HBV cccDNA, necessitating research into its formation and maintenance.
- Poly(ADP-ribose) polymerase 1 (PARP1) is implicated in converting HBV rcDNA to cccDNA.
Purpose of the Study:
- To elucidate the role of dedicator of cytokinesis 11 (DOCK11) in HBV cccDNA formation and maintenance.
- To investigate the molecular mechanisms underlying DOCK11's involvement in cccDNA synthesis.
- To assess DOCK11 as a potential therapeutic target for chronic HBV infection.
Main Methods:
- Utilized a minicircle HBV cccDNA reporter assay in DOCK11-depleted hepatoma cells.
- Performed cell-free assays with HBV rcDNA and nuclear extracts to assess DOCK11's effect on cccDNA formation.
- Employed co-immunoprecipitation and liquid chromatography-mass spectrometry to identify interacting proteins.
- Assessed PARP1 recruitment to DNA damage sites and its association with rcDNA in DOCK11 knockout cells.
Main Results:
- DOCK11 depletion significantly impaired HBV cccDNA maintenance and formation.
- DOCK11 overexpression enhanced cccDNA formation, while DOCK11 knockout suppressed it in cell-free assays.
- DOCK11 was found to form a multiprotein complex with HBV DNA, including PARP1.
- DOCK11 knockout reduced PARP1 recruitment to rcDNA, suggesting a role in facilitating PARP1 association.
Conclusions:
- DOCK11 promotes HBV cccDNA formation, likely by facilitating the recruitment and function of PARP1.
- DOCK11 represents a novel host factor crucial for HBV persistence.
- Targeting the DOCK11-PARP1 interaction offers a potential therapeutic strategy for eliminating HBV cccDNA and achieving a functional cure.
Related Concept Videos
Hepatitis
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers
Long-patch Base Excision Repair
Restarting Stalled Replication Forks
Viruses with RNA Genomes

